Stimcell Energetics (STME) Change in Accured Expenses (2011 - 2026)
Stimcell Energetics (STME) recorded quarterly Change in Accured Expenses of -$7646.0 in Q1 2026, up 67.14% quarter-over-quarter from -$23268.0 in Q4 2025, and down 117.46% on a YoY basis from $43783.9 in Q1 2025.
Stimcell Energetics (STME) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Stimcell Energetics' Change in Accured Expenses history runs 14 years deep, the most recent figure standing at -$7646.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 117.46% year-over-year to -$7646.0; the TTM figure through Feb 2026 stood at -$1068.0 (up 74.87% YoY), while the FY2025 annual figure was -$1108.0, up 86.96% from the prior year.
- Change in Accured Expenses was -$7646.0 for Q1 2026 at Stimcell Energetics, up from -$23268.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $24531.0 in Q2 2022 to a low of -$34146.0 in Q4 2023.
- Historically, Change in Accured Expenses has averaged $219.88 across 5 years, with a median of $3857.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses jumped 163.8% in 2022, then plunged 7454.42% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$452.0 in 2022, then slumped by 7454.42% to -$34146.0 in 2023, then soared by 116.58% to $5662.0 in 2024, then slumped by 510.95% to -$23268.0 in 2025, then soared by 67.14% to -$7646.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$7646.0 (Q1 2026), -$23268.0 (Q4 2025), and $11739.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Stimcell Energetics | - | - | - | -7,646.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7,646.00 |
| Feb 28, 2026 | -7,646.00 |
| Nov 30, 2025 | -23,268.00 |
| Nov 30, 2025 | -23,268.00 |
| Aug 31, 2025 | 11,739.00 |
| Aug 31, 2025 | 11,739.00 |
| May 31, 2025 | 18,107.00 |
| May 31, 2025 | 18,107.00 |
| Feb 28, 2025 | -3,516.00 |
| Feb 28, 2025 | -3,516.00 |
| Nov 30, 2024 | 5,662.00 |
| Nov 30, 2024 | 5,662.00 |
| Aug 31, 2024 | -21,361.00 |
| Aug 31, 2024 | -21,361.00 |
| May 31, 2024 | 14,965.00 |
| May 31, 2024 | 14,965.00 |
| Feb 29, 2024 | 4,765.00 |
| Feb 29, 2024 | 4,765.00 |
| Nov 30, 2023 | -34,146.00 |
| Nov 30, 2023 | -34,146.00 |